Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. M. PembrolizuMAb+Axitinib
>
Patent>UpDate: 2019. 12.31.
Patent>UpDate: 2019. 12.31.'s products
This section has no products